ReportGem ReportGem

U.S. COMPANY FILING

Merck & Co., Inc. — Form 8-K filed 2026-02-03

Filed: 2026-02-03Company: Merck & Co., Inc.Ticker: MRKExchange: NYSEForm: 8-KReport period: 2026-02-03SEC accession: 0001104659-26-009495Event: earningsMateriality: 0

Filing text preview

Merck filed an 8-K on February 3, 2026, reporting Q4 and full-year 2025 earnings via press release (Exhibit 99.1) and supplemental information (Exhibit 99.2). The report is furnished, not filed, and contains no specific financial figures.

This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.

Open filing record

Related research and intelligence

Official SEC filing2026-02-03Merck and Moderna's Melanoma Vaccine Trial Positive, Vaccine Themed ETFs Surge2026-08-20S&P 500 and Nasdaq Edge Higher, Led by Moderna and Merck2026-08-2010-Q2026-08-07 · 10-QFORM 8-K2026-08-04 · 8-K1Q26 FORM 10-Q2026-05-04 · 10-QFORM 8-K2026-04-30 · 8-K10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 20252026-02-24 · 10-K